Detail akcie Biotika online

Business Summary: Biotika as is a Slovakia-based joint stock company that specializes in biotechnology and production of pharmaceutical. The Company's activities are grouped into three main areas: biotechnological production of the substances of penicillin, chlorotetracycline and dextrans; production of final drug-forms for both human and veterinary use, including: penicillin and cephalosporin preparations, hormonal preparations, vitamin preparations; as well as production of premixes containing nutrition additives and medicated nutritive preparations. As of December 31, 2011, the Company operated two wholly owned subsidiaries, COV as Slovenska Lupca and Biotkika KLF as Slovenska Lupca.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2022, Biotika as revenues increased 24% to EUR11M. Net loss totaled EUR820K vs. income of EUR406K. Revenues reflect Substances segment increase of 18% to EUR8.7M, Services segment increase of 58% to EUR2.3M, Ghana segment increase from EUR12K to EUR1.5M, France segment increase from EUR15K to EUR996K. Net loss reflects Other Operating Income decrease of 52% to EUR747K (income).